Intellia Therapeutics
Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology.
Key facts
| Legal Name | Intellia Therapeutics, Inc. |
|---|---|
| Company Operating Status | Active |
| Full Address | 40 Erie Street Cambridge, MA 02139 United States |
| Stock Symbol | NTLA |
| Wellfound ID | intellia-therapeutics-2 |
| Wikidata ID | Q54621387 |